Factors That Influence the Prescription of Antipsychotics for Patients with Schizophrenia in China-Reference-Cited by-同舟云学术

Factors That Influence the Prescription of Antipsychotics for Patients with Schizophrenia in China

Published:2011-12-28 Issue:3 Volume:9 Page:122-128
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Si Tian-Mei¹,Shu Liang¹,Li Ke-Qing²,Liu Xie-He³,Mei Qi-Yi⁴,Wang Gao-Hua⁵,Bai Pei-Shen⁶,Ji Li-Ping⁷,Chen Xian-Sheng⁸,Ma Cui⁹,Shi Jian-Guo¹⁰,Zhang Hong-Yan¹,Ma Hong¹,Yu Xin¹

Affiliation:

1. Key Laboratory of Mental Health, Institute of Mental Health, Peking University, Beijing, China

2. Hebei Mental Health Center, Baoding, China

3. Mental Health Center of Huaxi Hospital, Sichuan University, Chengdu, China

4. Guangji Hospital, Suzhou, China

5. Department of Mental Health, People's Hospital of Wuhan, Wuchang, China

6. The First Hospital of Shanxi Medical University, Taiyuan, China

7. Jilin Neuro-Psychiatric Hospital, Siping, China

8. Jiangxi Mental Health Hospital, Nanchang, China

9. Guangzhou Mental Health Hospital, Guangzhou, China

10. Xi'An Mental Health Center, Xi'An, China

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2011/009/cpn-9-122.pdf

Reference30 articles.

1. Chen CH, Shen Y, Zhang WX, Li SR, Huang YQ, Wang JR, et al. Epidemiological Survey on schizophrenia in 7 areas of China. Chin J Psychiatry. 1998;31;72-74.

2. Consensus statement on the use and usefulness of second generation antipsychotic medication. Yokohama: World Congress of Psychiatry; .

3. Clozapine for the Treatment-Resistant Schizophrenic

4. Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials

5. Fang M, Hu SH, Wang Q. Investigaiton of psychotropic drugs therapy in hospitalized patients. Chengdu Med J. 2002;28;139-140.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of long acting injectable antipsychotic use and associated clinical factors in schizophrenia among 15 Asian countries and region;Asia-Pacific Psychiatry;2020-05-29

2. Randomized, double‐blind, 6‐week non‐inferiority study of lurasidone and risperidone for the treatment of schizophrenia;Psychiatry and Clinical Neurosciences;2020-01-08

3. Prescription practices in the treatment of agitation in newly hospitalized Chinese schizophrenia patients: data from a non-interventional naturalistic study;BMC Psychiatry;2019-07-10

4. Antipsychotic polypharmacy in the treatment of schizophrenia in China and Japan;Australian & New Zealand Journal of Psychiatry;2018-10-12

5. A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes;Psychiatry Research;2018-01